Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers

Neoplasma

Volumn 58, Issue 1, 2011, Pages 9-13

  Yu, L ^a   Wang, L ^a   Chen, S ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangdong Key Laboratory of Pharmaceutical Functional Genes   (China)

Author keywords

Gastrointestinal cancer; Olfactomedin 4; Tumor differentiation and progression; Tumor marker; Tumorigenesis

Indexed keywords

CADHERIN; LECTIN; MEMBRANE PROTEIN; OLFACTOMEDIN 4; TUMOR MARKER; UNCLASSIFIED DRUG; GRANULOCYTE COLONY STIMULATING FACTOR; OLFM4 PROTEIN, HUMAN;

CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; DIGESTIVE SYSTEM CANCER; HUMAN; IMMUNOREACTIVITY; METASTASIS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW; TUMOR DIFFERENTIATION; CELL DIFFERENTIATION; DISEASE COURSE; GASTROINTESTINAL TUMOR; GENETICS; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION;

CELL DIFFERENTIATION; DISEASE PROGRESSION; GASTROINTESTINAL NEOPLASMS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; PROMOTER REGIONS, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 79961103406     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_01_9     Document Type: Review

References (30)

1. SNYDER DA, RIVERS AM, YOKOE H, MENCO BP, ANHOLT RR. Olfactomedin: purification, characterization, and localization of a novel olfactory glycoprotein. Biochemistry 1991; 30: 9143-9153.
2. YOKOE H, ANHOLT RR. Molecular cloning of olfactomedin, an extracellular matrix protein specific to olfactory neuroepithelium. Proc Natl Acad Sci U S A 1993; 90: 4655-4659. doi:10.1073/pnas.90.10.4655
3. ZENG LC, HAN ZG, MA WJ. Elucidation of subfamily segregation and intramolecular coevolution of the olfactomedin-like proteins by comprehensive phylogenetic analysis and gene expression pattern assessment. FEBS Lett 2005; 579: 5443-5453. doi:10.1016/j.febslet.2005.08.064
4. TOMAREV SI, NAKAYA N. Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology. Mol Neurobiol 2009; 40: 122-138. doi:10.1007/s12035-009-8076-x
5. ZHANG X, HUANG Q, YANG Z, LI Y, LI CY. GW112, a novel antiapoptotic protein that promotes tumor growth. Cancer Res. 2004; 64: 2474-2481. doi:10.1158/0008-5472.CAN-03-3443
6. ZHANG J, LIU WL, TANG DC, CHEN L, WANG M et al. Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development. Gene 2002; 283: 83-93.
7. ROSENBAUER F, WAGNER K, ZHANG P, KNOBELOCH KP, IWAMA A et al. pDP4, a novel glycoprotein secreted by mature granulocytes, is regulated by transcription factor PU.1. Blood 2004; 103: 4294-4301. doi:10.1182/blood-2003-08-2688
8. KULKARNI NH, KARAVANICH CA, ATCHLEY WR, ANHOLT RR. Characterization and differential expression of a human gene family of olfactomedin-related proteins. Genet Res 2000; 76: 41-50. doi:10.1017/S0016672300004584
9. LIU W, CHEN L, ZHU J, RODGERS GP. The glycoprotein hGC-1 binds to cadherin and lectins. Exp Cell Res 2006; 312: 1785-1797. doi:10.1016/j.yexcr.2006.02.011
10. SHINOZAKI S, NAKAMURA T, IIMURA M, KATO Y, IIZUKA B et al. Upregulation of Reg 1alpha and GW112 in the epithelium of inflamed colonic mucosa. Gut 2001; 48: 623-629.
11. LIU W, ZHU J, CAO L, RODGERS GP. Expression of hGC1 is correlated with differentiation of gastric carcinoma. Histopathology 2007; 51: 157-165. doi:10.1111/j.1365-2559.2007.02763.x
12. TAKENAWA H, KUROSAKI M, ENOMOTO N, MIYASAKA Y, KANAZAWA N et al. Differential gene-expression profiles associated with gastric adenoma. Br J Cancer 2004; 90: 216-223. doi:10.1038/sj.bjc.6601399
13. AUNG PP, OUE N, MITANI Y, NAKAYAMA H, YOSHIDA K et al. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 2006; 25: 2546-2557. doi:10.1038/sj.onc.1209279
14. OUE N, AUNG PP, MITANI Y, KUNIYASU H, NAKAYAMA H. Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression. Oncology 2005; 69 Suppl 1: 17-22. doi:10.1159/000086627
15. OUE N, SENTANI K, NOGUCHI T, OHARA S, SAKAMOTO N et al. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer 2009; 125: 2383-2392. doi:10.1002/ijc.24624
16. KOSHIDA S, KOBAYASHI D, MORIAI R, TSUJI N, WATANABE N. Specific overexpression of OLFM4(GW112/ HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis. Cancer Sci 2007; 98: 315-320. doi:10.1111/j.1349-7006.2006.00383.x
17. WENTZENSEN N, WILZ B, FINDEISEN P, WAGNER R, DIPPOLD W et al. Identification of differentially expressed genes in colorectal adenoma compared to normal tissue by suppression subtractive hybridization. Int J Oncol 2004; 24: 987-994.
18. KOBAYASHI D, KOSHIDA S, MORIAI R, TSUJI N, WATANABE N. Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells. Cancer Sci 2007; 98: 334-340. doi:10.1111/j.1349-7006.2007.00397.x
19. KIM KK, PARK KS, SONG SB, KIM KE. Up regulation of GW112 Gene by NFkappaB promotes an antiapoptotic prop-. erty in gastric cancer cells. Mol Carcinog 2010; 49: 259-270.
20. CONROTTO P, ROESLI C, RYBAK J, KISCHEL P, WALTREGNY D et al. Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis. Int J Cancer 2008; 123: 2856-2864. doi:10.1002/ijc.23861
21. LIU W, LIU Y, ZHU J, WRIGHT E, DING I. Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma. Clin Cancer Res 2008; 14: 1041-1049. doi:10.1158/1078-0432.CCR-07-4125
22. VAN DER FLIER LG, HAEGEBARTH A, STANGE DE, VAN DE WETERING M, CLEVERS H. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology 2009; 137: 15-17. doi:10.1053/j.gastro.2009.05.035
23. VAN DER FLIER LG, VAN GIJN ME, HATZIS P, KUJALA P, HAEGEBARTH A et al. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 2009; 136: 903-912.
24. BARKER N, VAN ES JH, KUIPERS J, KUJALA P, VAN DEN BORN M et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449: 1003-1007. doi:10.1038/nature06196
25. BARKER N, RIDGWAY RA, VAN ES JH, VAN DE WETERING M, BEGTHEL H et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009; 457: 608-611. doi:10.1038/nature07602
26. O'BRIEN CA, POLLETT A, GALLINGER S, DICK JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-110. doi:10.1038/nature05372
27. RICCI-VITIANI L, LOMBARDI DG, PILOZZI E, BIFFONI M, TODARO M et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115. doi:10.1038/nature05384
28. CHIN KL, AERBAJINAI W, ZHU J, DREW L, CHEN L et al. The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor. Br J Haematol 2008; 143: 421-432. doi:10.1111/j.1365-2141.2008.07368. x
29. SCHWARTZ SA, HERNANDEZ A, MARK EVERS B. The role of NF-kappaB/IkappaB proteins in cancer: implications for novel treatment strategies. Surg Oncol 1999; 8: 143-153. doi:10.1016/S0960-7404(00)00012-8
30. ARLT A, GEHRZ A, MUERKOSTER S, VORNDAMM J, KRUSE ML et al. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 2003; 22: 3243-3251. doi:10.1038/sj.onc.1206390.